Drugs / Pentaeritrithyl tetranitrate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03669185 Comparator | Jul 2017 → Jul 2020 | fetal growth restriction | Jena University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pentaeritrithyl tetranitrate | “Pentaeritrithyl tetranitrate” NCT03669185 ↗ |
| Modality | Small molecule | “The organic nitrate pentaerithrityl tetranitrate (PETN) is widely used for the treatment of cardiovascular disease” PMID 31521118 ↗ Sep 2019 |